PXDC1 and acute myeloid leukemia: Furthermore, it was shown that transcriptional activation of PXDC1 using a CRISPR activation system increased the survival of an acute myeloid leukaemia cell line exposed to cytarabine, a molecule used in standard chemotherapeutic mix for this leukaemia, hence increasing the resistance of the cells to the chemotherapy58.